Roche Acquires Innovatis AG for its Product Portfolio in Cellular Analytics
Roche (Basel, Switzerland) will acquire 100% of Innovatis, AG (Bielefeld, Germany).
Roche (Basel, Switzerland) will acquire 100% of Innovatis, AG (Bielefeld, Germany). Innovatis is a provider of automated cell analysis solutions, especially focusing on cell counting, viability testing, and cell function analysis in research and bioproduction.
Innovatis will become a fully integrated part of Roche Applied Science, a global business area of the diagnostic division of Roche. The company will continue to develop and market products for cell analysis through Roche Applied Science’s worldwide network. The purchase price for this transaction is €15 million.
Novartis Acquisition of Regulus Therapeutics is Complete
June 25th 2025A key property included in the acquisition is farabursen, an investigational next-generation oligonucleotide targeting the microRNA miR-17 with preferential kidney exposure, intended to treat people with autosomal dominant polycystic kidney disease.
